UCal has core CRISPR patent revoked in Europe; ToolGen gets Cas9 boost at EPO - IAM Media
2025-12-15 • Google News
UCAL
NSEundefined 110.77-2.28%
Price Chart
Key Statistics
Market Cap
₹ 0
P/E Ratio
0.00
Revenue (TTM)
₹ 0
Volume
29.21K
52W High
₹ 0.00
52W Low
₹ 0.00
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
N/A
200-Day MA
N/A
52 Week High
N/A
52 Week Low
N/A
About UCAL
No description available.
Employees
N/A
Headquarters
N/A
CEO
N/A
Latest News
Olivarez College puts UCAL crown on the line vs formidable cast - MSN
6 days ago • Google News
UCAL Limited Announces Q3 FY26 Financial Results with Mixed Performance - scanx.trade
2 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg